BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 28188963)

  • 1. High-risk epithelial ovarian cancer patients for hereditary ovarian cancer.
    Chirasophon S; Manchana T; Teerapakpinyo C
    J Obstet Gynaecol Res; 2017 May; 43(5):929-934. PubMed ID: 28188963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2.
    Eoh KJ; Kim JE; Park HS; Lee ST; Park JS; Han JW; Lee JY; Kim S; Kim SW; Kim JH; Kim YT; Nam EJ
    Cancer Res Treat; 2018 Jul; 50(3):917-925. PubMed ID: 29020732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
    Ow GS; Ivshina AV; Fuentes G; Kuznetsov VA
    Cell Cycle; 2014; 13(14):2262-80. PubMed ID: 24879340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
    Phelan CM; Kuchenbaecker KB; Tyrer JP; Kar SP; Lawrenson K; Winham SJ; Dennis J; Pirie A; Riggan MJ; Chornokur G; Earp MA; Lyra PC; Lee JM; Coetzee S; Beesley J; McGuffog L; Soucy P; Dicks E; Lee A; Barrowdale D; Lecarpentier J; Leslie G; Aalfs CM; Aben KKH; Adams M; Adlard J; Andrulis IL; Anton-Culver H; Antonenkova N; ; Aravantinos G; Arnold N; Arun BK; Arver B; Azzollini J; Balmaña J; Banerjee SN; Barjhoux L; Barkardottir RB; Bean Y; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Birrer MJ; Bjorge L; Black A; Blankstein K; Blok MJ; Bodelon C; Bogdanova N; Bojesen A; Bonanni B; Borg Å; Bradbury AR; Brenton JD; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Bruinsma F; Brunet J; Buecher B; Butzow R; Buys SS; Caldes T; Caligo MA; Campbell I; Cannioto R; Carney ME; Cescon T; Chan SB; Chang-Claude J; Chanock S; Chen XQ; Chiew YE; Chiquette J; Chung WK; Claes KBM; Conner T; Cook LS; Cook J; Cramer DW; Cunningham JM; D'Aloisio AA; Daly MB; Damiola F; Damirovna SD; Dansonka-Mieszkowska A; Dao F; Davidson R; DeFazio A; Delnatte C; Doheny KF; Diez O; Ding YC; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dossus L; Duran M; Dürst M; Dworniczak B; Eccles D; Edwards T; Eeles R; Eilber U; Ejlertsen B; Ekici AB; Ellis S; Elvira M; ; Eng KH; Engel C; Evans DG; Fasching PA; Ferguson S; Ferrer SF; Flanagan JM; Fogarty ZC; Fortner RT; Fostira F; Foulkes WD; Fountzilas G; Fridley BL; Friebel TM; Friedman E; Frost D; Ganz PA; Garber J; García MJ; Garcia-Barberan V; Gehrig A; ; Gentry-Maharaj A; Gerdes AM; Giles GG; Glasspool R; Glendon G; Godwin AK; Goldgar DE; Goranova T; Gore M; Greene MH; Gronwald J; Gruber S; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harrington PA; Harris HR; Hauke J; ; Hein A; Henderson A; Hildebrandt MAT; Hillemanns P; Hodgson S; Høgdall CK; Høgdall E; Hogervorst FBL; Holland H; Hooning MJ; Hosking K; Huang RY; Hulick PJ; Hung J; Hunter DJ; Huntsman DG; Huzarski T; Imyanitov EN; Isaacs C; Iversen ES; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jernetz M; Jensen A; Jensen UB; John EM; Johnatty S; Jones ME; Kannisto P; Karlan BY; Karnezis A; Kast K; ; Kennedy CJ; Khusnutdinova E; Kiemeney LA; Kiiski JI; Kim SW; Kjaer SK; Köbel M; Kopperud RK; Kruse TA; Kupryjanczyk J; Kwong A; Laitman Y; Lambrechts D; Larrañaga N; Larson MC; Lazaro C; Le ND; Le Marchand L; Lee JW; Lele SB; Leminen A; Leroux D; Lester J; Lesueur F; Levine DA; Liang D; Liebrich C; Lilyquist J; Lipworth L; Lissowska J; Lu KH; Lubinński J; Luccarini C; Lundvall L; Mai PL; Mendoza-Fandiño G; Manoukian S; Massuger LFAG; May T; Mazoyer S; McAlpine JN; McGuire V; McLaughlin JR; McNeish I; Meijers-Heijboer H; Meindl A; Menon U; Mensenkamp AR; Merritt MA; Milne RL; Mitchell G; Modugno F; Moes-Sosnowska J; Moffitt M; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Nathanson KL; Nedergaard L; Ness RB; Neuhausen SL; Nevanlinna H; Niederacher D; Nussbaum RL; Odunsi K; Olah E; Olopade OI; Olsson H; Olswold C; O'Malley DM; Ong KR; Onland-Moret NC; ; Orr N; Orsulic S; Osorio A; Palli D; Papi L; Park-Simon TW; Paul J; Pearce CL; Pedersen IS; Peeters PHM; Peissel B; Peixoto A; Pejovic T; Pelttari LM; Permuth JB; Peterlongo P; Pezzani L; Pfeiler G; Phillips KA; Piedmonte M; Pike MC; Piskorz AM; Poblete SR; Pocza T; Poole EM; Poppe B; Porteous ME; Prieur F; Prokofyeva D; Pugh E; Pujana MA; Pujol P; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Rhiem K; Rice P; Richardson A; Robson M; Rodriguez GC; Rodríguez-Antona C; Romm J; Rookus MA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Salvesen HB; Sandler DP; Schoemaker MJ; Senter L; Setiawan VW; Severi G; Sharma P; Shelford T; Siddiqui N; Side LE; Sieh W; Singer CF; Sobol H; Song H; Southey MC; Spurdle AB; Stadler Z; Steinemann D; Stoppa-Lyonnet D; Sucheston-Campbell LE; Sukiennicki G; Sutphen R; Sutter C; Swerdlow AJ; Szabo CI; Szafron L; Tan YY; Taylor JA; Tea MK; Teixeira MR; Teo SH; Terry KL; Thompson PJ; Thomsen LCV; Thull DL; Tihomirova L; Tinker AV; Tischkowitz M; Tognazzo S; Toland AE; Tone A; Trabert B; Travis RC; Trichopoulou A; Tung N; Tworoger SS; van Altena AM; Van Den Berg D; van der Hout AH; van der Luijt RB; Van Heetvelde M; Van Nieuwenhuysen E; van Rensburg EJ; Vanderstichele A; Varon-Mateeva R; Vega A; Edwards DV; Vergote I; Vierkant RA; Vijai J; Vratimos A; Walker L; Walsh C; Wand D; Wang-Gohrke S; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; Whittemore AS; Wijnen JT; Wilkens LR; Wolk A; Woo M; Wu X; Wu AH; Yang H; Yannoukakos D; Ziogas A; Zorn KK; Narod SA; Easton DF; Amos CI; Schildkraut JM; Ramus SJ; Ottini L; Goodman MT; Park SK; Kelemen LE; Risch HA; Thomassen M; Offit K; Simard J; Schmutzler RK; Hazelett D; Monteiro AN; Couch FJ; Berchuck A; Chenevix-Trench G; Goode EL; Sellers TA; Gayther SA; Antoniou AC; Pharoah PDP
    Nat Genet; 2017 May; 49(5):680-691. PubMed ID: 28346442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
    Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KK; Anton-Culver H; Antonenkova N; ; ; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH; Orlow I; Orsulic S; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Budzilowska A; Sellers TA; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston L; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tworoger SS; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu AH; Yang H; Zheng W; Ziogas A; Coetzee GA; Freedman ML; Monteiro AN; Moes-Sosnowska J; Kupryjanczyk J; Pharoah PD; Gayther SA; Schildkraut JM
    Carcinogenesis; 2015 Nov; 36(11):1341-53. PubMed ID: 26424751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of function germline mutations in RAD51D in women with ovarian carcinoma.
    Wickramanayake A; Bernier G; Pennil C; Casadei S; Agnew KJ; Stray SM; Mandell J; Garcia RL; Walsh T; King MC; Swisher EM
    Gynecol Oncol; 2012 Dec; 127(3):552-5. PubMed ID: 22986143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.
    Sia TY; Maio A; Kemel YM; Arora KS; Gordhandas SB; Kahn RM; Salo-Mullen EE; Sheehan MA; Tejada PR; Bandlamudi C; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Tew WP; Long Roche K; Zivanovic O; Sonoda Y; Gardner GJ; Chi DS; Latham AJ; Carlo MI; Murciano-Goroff YR; Will M; Walsh MF; Robson ME; Mandelker DL; Berger MF; Abu-Rustum NR; Brown CL; Offit K; Hamilton JG; Aghajanian C; Weigelt B; Stadler ZK; Liu YL
    JCO Precis Oncol; 2023 Sep; 7():e2300137. PubMed ID: 37738546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
    Pavanello M; Chan IH; Ariff A; Pharoah PD; Gayther SA; Ramus SJ
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33086730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wise Management of Ovarian Cancer: On the Cutting Edge.
    Boussios S; Mikropoulos C; Samartzis E; Karihtala P; Moschetta M; Sheriff M; Karathanasi A; Sadauskaite A; Rassy E; Pavlidis N
    J Pers Med; 2020 May; 10(2):. PubMed ID: 32455595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic medical record documentation of germline genetic evaluations in patients with ovarian cancer.
    Batson M; Goldblatt LG; Pundock S; Arutyunov A; McKenna D; Haggerty A; Symecko H; Shah PD
    J Genet Couns; 2024 Apr; 33(2):314-321. PubMed ID: 37183564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis.
    Castro M; Vierkoetter K; Prager D; Montgomery S; Sedgwick K
    Case Rep Oncol; 2016; 9(2):387-394. PubMed ID: 27721756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial Cancer in a Family With RAD51D Gene Mutation.
    Gilmore B; Logan L; McKinnon W; Everett E; Bryant BH
    Int J Gynecol Pathol; 2024 Jul; 43(4):349-353. PubMed ID: 38661557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
    Riahi A; Chabouni-Bouhamed H; Kharrat M
    Cancer Genet; 2017 Jan; 210():22-27. PubMed ID: 28212807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].
    Tao T; Yang JX; Shen K; Cao DY
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):20-25. PubMed ID: 28190311
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids.
    Chen YA; Lu CY; Cheng WF; Kuo KT; Yu CW; Ho HN; Chen HF; Pan SH
    BMC Cancer; 2022 Sep; 22(1):967. PubMed ID: 36085021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of Ovarian Cancer and Ovarian Cancer Screening.
    Koshiyama M; Matsumura N; Konishi I
    Diagnostics (Basel); 2017 Mar; 7(1):. PubMed ID: 28257098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.
    Shah S; Cheung A; Kutka M; Sheriff M; Boussios S
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of
    Suszynska M; Kozlowski P
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32679805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.
    Suszynska M; Ratajska M; Kozlowski P
    J Ovarian Res; 2020 May; 13(1):50. PubMed ID: 32359370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.